2017
DOI: 10.1016/j.molmed.2017.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Disease Modeling in Stem Cell-Derived 3D Organoid Systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
537
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 662 publications
(541 citation statements)
references
References 108 publications
2
537
0
2
Order By: Relevance
“…Advances in generating tumoroids from pancreatic cancer [20], glioblastoma [21], prostate cancer [22,23] and colorectal cancer [3] reveal that patient-derived tumoroids recapitulate patient-specific histological features. These tumoroids can also be cryopreserved in a similar manner as continuous cell lines and can subsequently be characterized by genomics, transcriptomics and using high-throughput in vitro drug screening assays, something that has spurred initiatives to develop live patient-derived tumoroid biobanks [1]. It is possible that data from tumoroid drug screening assays not only will complement and corroborate tumor genomic data but may in addition provide prediction on drug responses where sequencing data alone might fall short.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Advances in generating tumoroids from pancreatic cancer [20], glioblastoma [21], prostate cancer [22,23] and colorectal cancer [3] reveal that patient-derived tumoroids recapitulate patient-specific histological features. These tumoroids can also be cryopreserved in a similar manner as continuous cell lines and can subsequently be characterized by genomics, transcriptomics and using high-throughput in vitro drug screening assays, something that has spurred initiatives to develop live patient-derived tumoroid biobanks [1]. It is possible that data from tumoroid drug screening assays not only will complement and corroborate tumor genomic data but may in addition provide prediction on drug responses where sequencing data alone might fall short.…”
Section: Discussionmentioning
confidence: 99%
“…Although the methodology to establish tissue in vitro cultures has been available for more than a century [1], the use of two dimensional (2D) culture techniques to establish continuous tumor cell lines from explanted tumor tissue cultures is hampered by artificial culture conditions that severely diminish the success rate, and tumor clonal heterogeneity. Further, time constraints render this approach impractical for clinical application to derive drug response profiles of tumors for specific patients.…”
Section: Priority Research Papermentioning
confidence: 99%
“…A way forward to overcome this limitation might be the use of organoids, self-organizing in vitro structures that include multiple cell types and mimic the in vivo architecture of an organ 30 . Despite the relative success in generating organoids mimicking development of the cerebral cortex (reviewed in 30,31 ), only one study has thus far reported the generation of cerebellar organoids.…”
Section: Generation Of Cerebellar Neurons Using Human Ipscsmentioning
confidence: 99%
“…Despite the relative success in generating organoids mimicking development of the cerebral cortex (reviewed in 30,31 ), only one study has thus far reported the generation of cerebellar organoids. Muguruma et al showed that the addition of Fgf19 and stromal cell-derived factor 1 (Sdf1) during differentiation promoted the self-organisation of human ESCs into polarized three-layer structures reminiscent of the human embryonic cerebellum 23 .…”
Section: Generation Of Cerebellar Neurons Using Human Ipscsmentioning
confidence: 99%
See 1 more Smart Citation